首页>
外国专利>
Modulators of cytokine-mediated signaling pathways and integrin αvβ3 receptor antagonists for combination therapy
Modulators of cytokine-mediated signaling pathways and integrin αvβ3 receptor antagonists for combination therapy
展开▼
机译：细胞因子介导的信号通路调节剂和整联蛋白αvβ3受体拮抗剂用于联合治疗
展开▼
页面导航
摘要
著录项
相似文献
摘要
The invention relates to the use of modulators of cytokine mediated signalling pathways in combination with integrin alphaSUBv/SUBbetaSUB3 /SUBreceptor antagonists for the treatment or prevention of diseases, particularly to the use of a pharmaceutical composition, comprising a modulator of cytokine mediated signalling pathways and an integrin alphaSUBv/SUBbetaSUB3 /SUBreceptor antagonist, for the treatment or prevention of inflammatory or autoimmune disorders, particularly for the treatment or prevention of rheumatoid arthritis and to the pharmaceutical composition itself.
展开▼
机译：本发明涉及细胞因子介导的信号传导调节剂与整联蛋白α v β 3 受体拮抗剂联合用于治疗或预防疾病的用途，特别涉及药物组合物，其包含细胞因子介导的信号传导途径的调节剂和整联蛋白α v β 3 受体拮抗剂，用于治疗或预防炎性或自身免疫性疾病，尤其是针对治疗或预防类风湿关节炎和药物组合物本身。
展开▼
